COVID-19 Clinical Management

While most COVID-19 infections cause only mild to moderate symptoms, severely affected patients, such as those presenting with pneumonia, ARDS or septic shock, require hospitalization. This feed focuses on clinical management of patients using oxygen therapy, ventilation, and other treatment strategies, and covers some medical case reports.

May 30, 2020

Morphology of COVID-19-affected cells in peripheral blood film

BMJ Case Reports
Aminder SinghAbhishek Goyal
May 31, 2020

COVID-19 pneumonia: phenotype assessment requires bedside tools

Critical Care : the Official Journal of the Critical Care Forum
Zhanqi ZhaoInéz Frerichs
May 30, 2020

Postintubation Dysphagia During COVID-19 Outbreak-Contemporary Review

Zofia FrajkovaAhmed Geneid
May 31, 2020

Phenotypic characteristics and prognosis of inpatients with COVID-19 and diabetes: the CORONADO study

Bertrand CariouCORONADO investigators
May 30, 2020

Surgical mask dermatitis caused by formaldehyde (releasers) during the COVID-19 pandemic

Contact Dermatitis
Olivier AertsJulien Lambert
May 31, 2020

We Know About COVID-19: Oral and Maxillofacial Surgeons Survey

The Journal of Craniofacial Surgery
Samuel Macedo CostaMarcio Bruno Figueiredo Amaral
May 31, 2020

Control measures to prevent Coronavirus disease 2019 (COVID-19)pandemic in endoscopy centers: a multi-centre study

Digestive Endoscopy : Official Journal of the Japan Gastroenterological Endoscopy Society
Qing HuangYulan Liu
May 30, 2020

Clinical Characteristics and Outcomes of COVID-19 Patients With a History of Stroke in Wuhan, China

Stroke; a Journal of Cerebral Circulation
Chuan QinWei Wang
June 1, 2020

Pharmacokinetics of Favipiravir in Critically Ill Patients with COVID-19

Clinical and Translational Science
Kei IrieTohru Hashida
May 31, 2020

Brainstem involvement and respiratory failure in COVID-19

Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
Fiore ManganelliGiuseppe Servillo
May 31, 2020

Detection of air and surface contamination by SARS-CoV-2 in hospital rooms of infected patients

Nature Communications
Po Ying ChiaSingapore 2019 Novel Coronavirus Outbreak Research Team
May 31, 2020

COVID-19 and diabetes: Is there enough evidence?

The Journal of Clinical Hypertension
Marijana TadicCarla Sala

Sign up to follow this feed and discover related papers.

Related Feeds

AI-driven COVID-19 Management

Artificial intelligence (AI) offers a powerful new tool that could potentially be instrumental in controling and managing the SARS-CoV-2 virus. The papers in this feed report on the applications of AI to the current pandemic, which may be able to predict the location of the next outbreak, or facilitate new drug design.


Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

COVID-19 Clinical Diagnosis

COVID-19 patients typically present with high fever and a persistent cough. This feed focuses on clinical diagnosis, including RT-PCR testing for the presence of SARS-CoV-2 and radiographic assessment of lungs.

COVID-19 Comorbidities

COVID-19 represents a particular challenge to people with serious chronic medical conditions such as diabetes, hypertension, cardiovascular disease, and chronic lung disease. Research into the intersection between comorbidities and COVID-19 is focusing on risks and treatment outcomes for these patients.

COVID-19 Complications

A growing number of complications associated with COVID-19 has been identified. This feed focuses primarily on cardiovascular and respiratory manifestations in severely ill patients.

COVID-19 Covalescent Plasma Therapy

Convalescent plasma therapy, where passive polyclonal antibody obtained from recovered patients are used to provide immediate immunity, has been tested in respiratory infections such as the 2009-2010 H1N1 influenza virus pandemic and the 2003 SARS-CoV-1 epidemic. This feed follows ongoing research efforts and clinical trials exploring covalescent plasma therapy as a potential treatment strategy for COVID-19.

COVID-19 Epidemiology and Demography

Epidemiological studies play a crucial role in understanding and managing the progression of COVID-19. Research followed in this feed includes studies of transmission dynamics and the change of the basic reproductive number (R) as new pubic health measures take effect.

COVID-19 Immune Response

Understanding the innate and acquired immune response to SARS-CoV-2 is essential for development of COVID-19 therapeutic treatment and design of prophylactic vaccines. This feed surfaces immunological studies, including studies into the cytokine storm that has been observed in severely ill patients.

COVID-19 Immunopathology

The research highlighted in this feed investigates the immunopathology seen in severely ill COVID-19 patients, which often resembles the cytokine storm syndrome: uncontrolled immune activation generates excessive release of cytokines, resulting in hyperinflammation and multi-organ disease.

COVID-19 Neurologic Manifestations

COVID-19 patients frequently have neurological symptoms, which are probably caused by the virus invading the central nervous system. Symptoms range from a loss of smell and taste to serious complications such as encephalitis, many of which are associated with poor prognosis. This feed follows the latest developments and research into the neurological complications associated with COVID-19.

© 2020 Meta ULC. All rights reserved